| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
30,804
|
16,696
|
12,493
|
6,321
| | Cost of Revenue | 3,027 | 1,386 | 610 | 630 | | |
Gross Profit
|
27,777
|
15,310
|
11,883
|
5,691
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 9,787 | 6,343 | 3,457 | 22,915 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others | 13,373 | 6,631 | 4,580 | 2,467 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
4,617
|
2,336
|
3,846
|
(19,691)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (3,607) | (1,508) | (2,179) | 4,044 |
|
Earnings Before Interest And Taxes | 1,010 | 828 | 1,667 | (15,647) |
|
Interest Expense | 1,084 | 99 |
-
|
-
|
|
Income Before Tax | (74) | 729 | 1,667 | (15,647) |
|
Income Tax Expense |
-
|
-
|
-
|
-
|
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (74) | 729 | 1,667 | (15,647) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(74)
|
729
|
1,667
|
(15,647)
| | Preferred Stock And Other Adjustments | (2,072) | (1,848) | (264) |
-
| | |
Net Income Applicable To Common Shares
|
(2,146)
|
(1,119)
|
1,403
|
(15,647)
|
|
0.00(0.00%) 1:53PM EDT - Nasdaq Real Time Price